Cowen Starts Neuroderm Ltd (NDRM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Roth Capital Starts Neuroderm Ltd (NDRM) at Buy
December 9, 2014 7:08 AM ESTRoth Capital initiated coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.50.
For an analyst ratings summary and ratings history on Neuroderm Ltd click here. For more ratings news on Neuroderm Ltd click here.
Shares of Neuroderm Ltd closed at $8.04 yesterday.
... MoreJefferies Starts Neuroderm Ltd (NDRM) at Buy, $17 PT
December 9, 2014 6:49 AM ESTJefferies initiates coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.00.
Analyst Thomas Wei said, "We view NDRM's Parkinsons disease (PD) assets, ND0612L and ND0612H, as two relatively de-risked drugs among mid-stage biotech... More
